Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Subscribe!
Subscribe Today!
Home
/
Tags
/
KYV-101
KYV-101
| 5 min read
by
Luisa Torres, PhD
Kyverna Therapeutics tests CAR T cells for autoimmune disease
Rheumatologist James Chung leads efforts to expand CAR T cell therapy beyond the oncology field.
News
Page 1 of 1 - 1 Total Items
1
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
How new alternative methods are changing drug safety testing
Can animal testing be replaced? Discover how scientists are developing more human-relevant ways to predict drug toxicity earlier.
Video
Post-surgical management strategies for reliable preclinical rodent studies
Learn about common challenges and proper maintenance practices for catheterized rodent models.
Webinars
Building stronger AI foundations for drug discovery
Learn why data quality, governance, and collaboration are critical to realizing AI’s potential across the drug discovery pipeline.
Articles
Latest Issue
Volume 21 • Issue 4 • December 2025
December 2025
December 2025 Issue
Explore this issue